Our analysis highlights the FFAR2 and FFAR3 distribution in different cardiac tissue, cell types, and infarction areas, uncovering the potential effect and mechanisms of SCFAs via FFAR2 and FFAR3 in the heart, and provides a valuable reference for future studies. This evidence concerns the gene FFAR3 and infarction.